Uganda Cancer Institute Pilots AI Technology for Cervical Cancer Screening

Health experts and artificial intelligence specialists in Uganda are integrating advanced technology into healthcare to tackle cervical cancer, which remains the leading cause of cancer-related mortality among patients in the country.

As part of these efforts, a pilot project has been introduced utilizing an artificial intelligence-powered handheld screening device named CerviCARE. Developed in South Korea, the technology is being implemented through a collaborative initiative involving the Uganda Cancer Institute (UCI) alongside the Korea Foundation for International Healthcare (KOFIH) and the Ministry of Health.

Cervical cancer continues to pose a massive public health challenge across the nation. Recent statistics indicate that it stands as the most frequently diagnosed cancer in Uganda, accounting for 1,572 cases or roughly 15 percent of all newly diagnosed patients. Health authorities hope that incorporating AI tools like CerviCARE into routine practices will streamline early detection, bridge gaps in screening coverage, and ultimately save lives.

Medical professionals believe that leveraging portable AI solutions could significantly transform regional healthcare delivery, especially in areas where traditional diagnostic infrastructure is limited. Stakeholders gathered recently in Kampala to review the ongoing implementation and discuss broader strategies for strengthening the country’s cancer response.

For more details on this initiative, read the Daily Monitor report.